This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,255.79, is for the delivery of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of November 14, 2023 and is a Firm Fixed Price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,368.22, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025 and was awarded on February 3, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,682.52, is for the delivery of ELIQUIS 5 MG TABLET 60S, a medication used for various cardiovascular health conditions. The contract is a firm fixed-price arrangement with an ultimate completion date of August 30, 2022. This delivery order is part of a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The $5,441.47 contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication. The award has an ultimate completion date of August 23, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication, with a ceiling value of $13,258.28 and a period of performance through December 19, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a medication, with a firm fixed price ceiling value of $9,118.27. The contract has an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The $7,064.67 contract has a completion date of November 15, 2024 and was awarded on November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The contract, valued at $12,573.69, has a firm fixed price and an ultimate completion date of August 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,827.72 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a medication used for cardiovascular health, and has a ceiling value of $10,725.68. It is a firm fixed-price delivery order contract with a period of performance through November 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...